Edgewise Therapeutics (EWTX) Research & Development (2020 - 2026)
Edgewise Therapeutics' Research & Development came in at $47.55 million for Q2 2026, up 41.7% from $33.56 million a year earlier and up 11.5% from the prior quarter.
Powered by 
Analysis
Edgewise Therapeutics (EWTX) Research & Development (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Edgewise Therapeutics reported Research & Development of $171.27 million, up 23.3% year-over-year; for FY2025, it was $151.39 million, up 19.2% from FY2024.
- Research & Development has increased in each of the last five years, with a five-year compound annual growth rate of 58.8% (FY2020 to FY2025).
- Going back by year, Research & Development was $126.97 million in FY2024 (+39.7%), $90.91 million in FY2023 (+68.2%), $54.03 million in FY2022 (+67.9%) and $32.19 million in FY2021 (+114.8%).
- The Q2 2026 figure represents the highest quarterly Research & Development in data going back to Q1 2020.
- Year-over-year, Research & Development has increased for 22 consecutive quarters, with growth averaging 25.4% over the last eight quarters.
- Over the past five years, the year-over-year growth in Research & Development ranged from 9.4% (Q2 2025) to 205.1% (Q3 2021).
- Business Quant data shows EWTX's Research & Development at $42.65 million (Q1 2026), $43.59 million (Q4 2025) and $37.48 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.43 Bn | 1,102.02 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 615.31 Bn | 533.83 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 505.93 Bn | 479.05 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 367.07 Bn | 321.44 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.69 Bn | 261.68 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.59 Bn | 235.28 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.28 Bn | 191.68 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.31 Bn | 164.51 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.69 Bn | 117.33 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Edgewise Therapeutics | 4.31 Bn | 2.73 Bn | - | 47.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.55 Mn |
| Mar 31, 2026 | 42.65 Mn |
| Dec 31, 2025 | 43.59 Mn |
| Sep 30, 2025 | 37.48 Mn |
| Jun 30, 2025 | 33.56 Mn |
| Mar 31, 2025 | 36.76 Mn |
| Dec 31, 2024 | 36.37 Mn |
| Sep 30, 2024 | 32.22 Mn |
| Jun 30, 2024 | 30.68 Mn |
| Mar 31, 2024 | 27.69 Mn |
| Dec 31, 2023 | 27.68 Mn |
| Sep 30, 2023 | 23.79 Mn |
| Jun 30, 2023 | 19.56 Mn |
| Mar 31, 2023 | 19.88 Mn |
| Dec 31, 2022 | 16.61 Mn |
| Sep 30, 2022 | 13.89 Mn |
| Jun 30, 2022 | 12.40 Mn |
| Mar 31, 2022 | 11.12 Mn |
| Dec 31, 2021 | 9.09 Mn |
| Sep 30, 2021 | 9.88 Mn |
API Access
Edgewise Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=EWTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "EWTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=EWTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();